【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000196 Size: 8 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000194 Size: 8 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-20-065212 Act: 34 Size: 46 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2020-03-04,总裁 and CEO,Thatcher Christopher ,期权,20000普通股, $0.87
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-007077 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001564590-20-008474 Act: 34 Size: 34 KB 网页链接
$Neuronetics(STIM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-008464 Act: 34 Size: 14 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-008259 Act: 34 Size: 719 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 1.01, 1.02, 2.03, and 9.01 Accession Number: 0001193125-20-059619 Act: 34 Size: 445 KB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000905718-20-000229 Act: 34 Size: 38 KB 网页链接